Peer Review reports
From: Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus
Original Submission | ||
---|---|---|
19 Aug 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
3 Sep 2021 | Reviewed | Reviewer Report |
7 Sep 2021 | Reviewed | Reviewer Report - Konstantinos Tselios |
12 Nov 2021 | Author responded | Author comments - Yanli Zeng |
Resubmission - Version 3 | ||
12 Nov 2021 | Submitted | Manuscript version 3 |
18 Nov 2021 | Author responded | Author comments - Yanli Zeng |
Resubmission - Version 4 | ||
18 Nov 2021 | Submitted | Manuscript version 4 |
24 Nov 2021 | Author responded | Author comments - Yanli Zeng |
Resubmission - Version 5 | ||
24 Nov 2021 | Submitted | Manuscript version 5 |
Publishing | ||
30 Nov 2021 | Editorially accepted | |
27 Dec 2021 | Article published | 10.1186/s12865-021-00469-x |
You can find further information about peer review here.